Biostrandâ® Unveils A Revolutionary Approach To Biological Sequence Retrieval: A Fusion Of Natural Language Processing And Database Research

ImmunoPrecise Antibodies Ltd. (IPA) is thrilled to announce that its subsidiary, BioStrand, has published a preprint of its groundbreaking white paper titled, “New Paradigm for Biological Sequence Retrieval Inspired by Natural Language Processing and Database Research” on bioRχiv. The publication delves into the intricacies of one of BioStrand’s applications based on its patented HYFT-based methodology, a novel and proprietary approach to biological sequence retrieval, and its clear advantages over the gold standard algorithm, Basic Local Alignment Search Tool “BLAST”. BioStrand has also successfully rolled out its next-generation unified knowledge graph-Large Language Model (LLM) framework for holistic life sciences research, which is at the core of their LENSai platform.